Identity
- Security key
- 11862
- Ticker
- ARCT
- Type
- CS — Common Stock
- Exchange
- Nasdaq(XNAS)
- Venue group
- NASDAQ
- Operating MIC
- XNAS
- Market
- stocks
- Locale
- us
- Currency
- USD
- Listed
- 2013-05-22
- Round lot
- 100
- Active
- Yes
- Last seen in a load
- 2026-08-14 20:49
- Vendor updated
- 2026-08-13 06:09
- Ticker root / suffix
- ARCT
Detail
Enriched 2026-08-14 20:47
- Market cap
- $216,015,324.4
- Shares outstanding (class)
- 28,423,069
- Shares outstanding (weighted)
- 28,423,069
- SIC
- 2834 PHARMACEUTICAL PREPARATIONS
- Employees
- 111
- Location
- SAN DIEGO, CA
- Homepage
- https://www.arcturusrx.com
- Description
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on the development of infectious disease vaccines and opportunities within liver and respiratory rare diseases. It operates in one business segment, which includes all activities related to the discovery, development, and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC and LUNAR-CF. Its Vaccine candidates include LUNAR-FLU, KOSTAIVE XBB.1.5, KOSTAIVE, and Others.